4 December 2023
- 17:5217:52, 4 December 2023 diff hist +74 Scholarship: Applications of medical physics in radiotherapy (Mediterranean Institute of Oncology) No edit summary
- 17:5217:52, 4 December 2023 diff hist +74 Experts (Mediterranean Institute of Oncology) No edit summary
- 17:5117:51, 4 December 2023 diff hist +25 Mediterranean Institute of Oncology →Trials (Mediterranean Institute of Oncology)
- 17:5117:51, 4 December 2023 diff hist +5 Trials (Mediterranean Institute of Oncology) No edit summary
- 17:5017:50, 4 December 2023 diff hist +11,290 N Trials (Mediterranean Institute of Oncology) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Mediterranean Institute of Oncology '''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (N..."
- 17:5017:50, 4 December 2023 diff hist −5 Mediterranean Institute of Oncology →Trials
- 17:1817:18, 4 December 2023 diff hist +63 Resource: Telemedicine (Candiolo Cancer Institute) No edit summary
- 17:1817:18, 4 December 2023 diff hist +63 Facility: Candiolo Hotel (Candiolo Cancer Institute) No edit summary
- 17:1717:17, 4 December 2023 diff hist +63 Facility: Candiolo House "La Madonnina" (Candiolo Cancer Institute) No edit summary
- 17:1717:17, 4 December 2023 diff hist +63 Resource: Service Card (Candiolo Cancer Institute) No edit summary
- 17:1717:17, 4 December 2023 diff hist +63 Novel Therapies and Diagnostic Methods (Candiolo Cancer Institute) No edit summary
- 17:1617:16, 4 December 2023 diff hist +64 Experts (Candiolo Cancer Institute) No edit summary
- 17:1617:16, 4 December 2023 diff hist +25 Candiolo Cancer Institute →Trials (Candiolo Cancer Institute)
- 17:1517:15, 4 December 2023 diff hist +100,869 N Trials (Candiolo Cancer Institute) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Candiolo Cancer Institute page '''NCTID''': NCT04296890 '''Title''': A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression '''Study Summary''': This study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with platinum-res..."
- 17:1417:14, 4 December 2023 diff hist −5 Candiolo Cancer Institute →Trials
- 17:1417:14, 4 December 2023 diff hist +59 Facility: Animal welfare activities (Ospedale San Raffaele) No edit summary
- 17:1417:14, 4 December 2023 diff hist +59 Facility: Gift Shops (Ospedale San Raffaele) No edit summary
- 17:1317:13, 4 December 2023 diff hist +59 Facility: Supermarket (Ospedale San Raffaele) No edit summary
- 17:1317:13, 4 December 2023 diff hist +59 Facility: Hair Salon (Ospedale San Raffaele) No edit summary
- 17:1317:13, 4 December 2023 diff hist +59 Facility: Holy Mass (Ospedale San Raffaele) No edit summary
- 17:1317:13, 4 December 2023 diff hist +59 Facility: Gym (Ospedale San Raffaele) No edit summary
- 17:1317:13, 4 December 2023 diff hist +59 Resource: Religious Assistance (Ospedale San Raffaele) No edit summary
- 17:1217:12, 4 December 2023 diff hist +59 Resource: Linguistic Mediator (Ospedale San Raffaele) No edit summary
- 17:1217:12, 4 December 2023 diff hist +59 Resource: Home X-Ray Service (Ospedale San Raffaele) No edit summary
- 17:1217:12, 4 December 2023 diff hist +59 Resource: Telemedicine (Ospedale San Raffaele) No edit summary
- 17:1217:12, 4 December 2023 diff hist +59 Associations List (Ospedale San Raffaele) No edit summary
- 17:1117:11, 4 December 2023 diff hist +59 Novel Therapies and Diagnostic Methods (Ospedale San Raffaele) No edit summary
- 17:1117:11, 4 December 2023 diff hist +60 Course: PhD Program (Ospedale San Raffaele) No edit summary
- 17:1117:11, 4 December 2023 diff hist +60 Courses: Vita-Salute San Raffaele University (Ospedale San Raffaele) No edit summary
- 17:1017:10, 4 December 2023 diff hist +60 Experts (Ospedale San Raffaele) No edit summary
- 17:1017:10, 4 December 2023 diff hist +25 Ospedale San Raffaele →Trials (Ospedale San Raffaele)
- 17:0917:09, 4 December 2023 diff hist +424,959 N Trials (Ospedale San Raffaele) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Ospedale San Raffaele page '''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard..."
- 17:0817:08, 4 December 2023 diff hist −5 Ospedale San Raffaele →Trials
- 17:0717:07, 4 December 2023 diff hist +93 Associations List (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0717:07, 4 December 2023 diff hist +93 Facility: Religious Assistance (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0617:06, 4 December 2023 diff hist +93 Resource: Publications for patients (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0617:06, 4 December 2023 diff hist +93 Novel Therapies and Diagnostic Methods (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0617:06, 4 December 2023 diff hist +94 Training: Trainings and Events (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0517:05, 4 December 2023 diff hist +94 Experts (IRCCS Centro di Riferimento Oncologico della Basilicata) No edit summary
- 17:0517:05, 4 December 2023 diff hist +25 IRCCS Centro di Riferimento Oncologico della Basilicata →Trials (IRCCS Centro di Riferimento Oncologico della Basilicata)
- 17:0417:04, 4 December 2023 diff hist +29,053 N Trials (IRCCS Centro di Riferimento Oncologico della Basilicata) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to IRCCS Centro di Riferimento Oncologico della Basilicata page '''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine..."
- 17:0417:04, 4 December 2023 diff hist −5 IRCCS Centro di Riferimento Oncologico della Basilicata →Trials
- 17:0317:03, 4 December 2023 diff hist +124 Facility: Library (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0317:03, 4 December 2023 diff hist +124 Resource: Center for the Prevention and Treatment of Smoking and Smoking-related Diseases (CPCT) (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0317:03, 4 December 2023 diff hist +124 Resource: Service Card (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0317:03, 4 December 2023 diff hist +124 Resource: Religious Assistance (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0217:02, 4 December 2023 diff hist +124 Associations List (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0217:02, 4 December 2023 diff hist +124 Novel Therapies and Diagnostic Methods (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0117:01, 4 December 2023 diff hist +144 Trainings: Events, conferences and courses (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
- 17:0117:01, 4 December 2023 diff hist +125 Experts (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) No edit summary
